CCAP (Crescent Capital BDC) EPS without NRI: $0.41 (TTM As of Mar. 2026)


CCAP Crescent Capital BDC Inc CCAP
49 GF Score
Price $11.28
GF Value $6.79
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Crescent Capital BDC EPS without NRI?

Crescent Capital BDC CCAP +1.44% 49 EPS without NRI is $0.41 as of Mar. 2026. GuruFocus rates CCAP with a GF Score™ of 49/100 and a GF Value™ of $6.79 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 831 Asset Management companies, Crescent Capital BDC ranks better than 62.45% on this metric.

Crescent Capital BDC's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $-0.42. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.41.

During the past 12 months, Crescent Capital BDC's average earnings per share (NRI) Growth Rate was -69.40% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 23.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -9.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Crescent Capital BDC's EPS without NRI or its related term are showing as below:

CCAP' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -20.1   Med: 23   Max: 120.3
Current: 23

During the past 10 years, Crescent Capital BDC's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 120.30% per year. The lowest was -20.10% per year. And the median was 23.00% per year.

CCAP's 3-Year EPS without NRI Growth Rate is ranked better than
62.45% of 831 companies
in the Asset Management industry
Industry Median: 12.1 vs CCAP: 23.00

Crescent Capital BDC's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.42. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.41.

Crescent Capital BDC's EPS (Basic) for the three months ended in Mar. 2026 was $-0.42. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.41.


Crescent Capital BDC  (NAS:CCAP) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Crescent Capital BDC EPS without NRI Related Terms


Crescent Capital BDC EPS without NRI Historical Data

* Premium members only.

The historical data trend for Crescent Capital BDC's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crescent Capital BDC EPS without NRI Chart

Crescent Capital BDC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.94 0.50 2.33 1.99 0.93

Crescent Capital BDC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.41 0.19 0.23 -0.42

CCAP vs INV, LEO, VKI: EPS without NRI Comparison

For the Asset Management subindustry, Crescent Capital BDC's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Crescent Capital BDC PE Ratio without NRI vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Crescent Capital BDC's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Crescent Capital BDC's PE Ratio without NRI falls into.


CCAP
49GF Score
Crescent Capital BDC Inc CCAP
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crescent Capital BDC EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.41 mean?
Crescent Capital BDC (CCAP) has a EPS without NRI of $0.41 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Crescent Capital BDC and its competitors. According to the industry distribution chart, Crescent Capital BDC ranks #312 out of 831 companies in the Asset Management industry, placing it in the top 37.5%.
Is Crescent Capital BDC's EPS without NRI too high?
Crescent Capital BDC's current EPS without NRI is $0.41. The Asset Management industry median EPS without NRI is 12.10. Crescent Capital BDC's value of $0.41 is 96.6% below this industry median. Based on the distribution chart, Crescent Capital BDC ranks #312 out of 831 companies in the Asset Management industry, which is above the industry midpoint. Overall, Crescent Capital BDC has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crescent Capital BDC's EPS without NRI compare to INV and LEO?
According to the Asset Management industry distribution chart, Crescent Capital BDC ranks #312 out of 831 companies for EPS without NRI. This puts Crescent Capital BDC in the upper half of its industry. The industry median EPS without NRI is 12.10. Crescent Capital BDC's value of $0.41 is 96.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Asset Management company?
The median EPS without NRI among Asset Management companies is 12.10, based on 831 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crescent Capital BDC's current EPS without NRI of $0.41 is 96.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Crescent Capital BDC and its competitors. For the Asset Management industry, the median EPS without NRI is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crescent Capital BDC's current EPS without NRI is $0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crescent Capital BDC stock overvalued right now?
Based on GuruFocus' analysis, Crescent Capital BDC (CCAP) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.79, compared to a current price of $11.28 — trading 66.1% above its estimated fair value. The current EPS without NRI is $0.41 and 96.6% below the Asset Management industry median of 12.10. Crescent Capital BDC's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Crescent Capital BDC (CCAP), the current EPS without NRI is $0.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crescent Capital BDC (CCAP) Overvalued in 2026?

Based on GuruFocus' analysis, Crescent Capital BDC stock appears to be overvalued. The current stock price of $11.28 is trading 66.1% above its estimated GF Value™ of $6.79. GuruFocus considers Crescent Capital BDC to be Significantly Overvalued.

Key valuation signals for CCAP:

  • EPS without NRI: $0.41
  • GF Value™: $6.79 vs. price of $11.28 (66.1% above fair value)
  • GF Score™: 49/100 with 4 warning signs
  • Industry Position: 96.6% below the Asset Management median (#312 of 831)

No single metric tells the full story. See the CCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Crescent Capital BDC Business Description

Other Exchanges 487:Germany
Address 11100 Santa Monica Boulevard, Suite 2000, Los Angeles, CA, USA, 90025
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
49GF Score

Get the complete analysis for CCAP

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.28
Price
$6.79
GF Value